Pondering The Future Of In-Person Meetings At The US FDA
Executive Summary
Stakeholders believe virtual meetings should remain an option going forward, but that in-person sessions should still be convened in many cases.
You may also be interested in...
Some US FDA Advisory Committee Meetings Likely To Remain Virtual Post-Pandemic
Peter Stein says FDA will set criteria for holding a virtual meeting and will be seeking stakeholder feedback.
BIO 2021 Notebook: Looking Past The Pandemic
News and views from day one of the BIO Digital annual meeting include debate about when FDA will go back to the offices, industry's role in pandemic-related policy discussions and how to prepare for the next pandemic.
BIO 2021 Notebook: Looking Past The Pandemic
News and views from day one of the BIO Digital annual meeting include debate about when FDA will go back to the offices, industry's role in pandemic-related policy discussions and how to prepare for the next pandemic.